Syk protein has a crucial role in transmitting signaling from the BCR and from other receptors, such as CXCR4, providing it with an outstanding relevance as a therapeutic target for CLL [10, 11]. This evidence concerns the gene CXCR4 and B-cell chronic lymphocytic leukemia.